How critical is the blood-brain barrier to the development of neurotherapeutics?

Carmen Kut; Stuart A. Grossman; Jaishri Blakeley

doi:10.1001/jamaneurol.2014.3736

How critical is the blood-brain barrier to the development of neurotherapeutics?

Carmen Kut, Stuart A. Grossman, Jaishri Blakeley

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	381-382
Number of pages	2
Journal	JAMA Neurology
Volume	72
Issue number	4
DOIs	https://doi.org/10.1001/jamaneurol.2014.3736
State	Published - Apr 1 2015

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1001/jamaneurol.2014.3736

Cite this

@article{d09509a212e14f858b1fb2a64fad1400,

title = "How critical is the blood-brain barrier to the development of neurotherapeutics?",

author = "Carmen Kut and Grossman, {Stuart A.} and Jaishri Blakeley",

year = "2015",

month = apr,

day = "1",

doi = "10.1001/jamaneurol.2014.3736",

language = "English (US)",

volume = "72",

pages = "381--382",

journal = "JAMA Neurology",

issn = "2168-6149",